Works matching IS 10781552 AND DT 2019 AND VI 25 AND IP 1
Results: 38
Does oncology research need to slow down a little bit?
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 247, doi. 10.1177/1078155218785238
- By:
- Publication type:
- Article
Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 214, doi. 10.1177/1078155218785002
- By:
- Publication type:
- Article
Challenges of dispensing costly tablets with short shelf-life.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 210, doi. 10.1177/1078155218777815
- By:
- Publication type:
- Article
Pharmacy workload benchmarking: Establishing a health-system outpatient infusion productivity metric.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 172, doi. 10.1177/1078155217730663
- By:
- Publication type:
- Article
FLT3 inhibitors in acute myeloid leukemia: Current and future.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 163, doi. 10.1177/1078155218802620
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2019
- Publication type:
- Correction Notice
Shared decision making can aid the informed consent process for end-of-life chemotherapy in cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 249, doi. 10.1177/1078155218791346
- By:
- Publication type:
- Article
Informed consent for end-of-life chemotherapy in cancer patients: To what extent should we inform patients of our personal opinion?
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 250, doi. 10.1177/1078155218791323
- By:
- Publication type:
- Article
Successful use of uridine triacetate (Vistogard) three weeks after capecitabine in a patient with homozygous dihydropyrimidine dehydrogenase mutation: A case report and review of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 234, doi. 10.1177/1078155217732141
- By:
- Publication type:
- Article
Durable complete remission following anti-EGFR antibodies in recurrent metastatic colorectal cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 239, doi. 10.1177/1078155217730130
- By:
- Publication type:
- Article
A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 130, doi. 10.1177/1078155218783814
- By:
- Publication type:
- Article
Role of cyclin-dependent kinase 4/6 inhibitors in the current and future eras of cancer treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 110, doi. 10.1177/1078155218770904
- By:
- Publication type:
- Article
Assessment of bleeding incidences associated with rivaroxaban therapy in adults with solid tumors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 192, doi. 10.1177/1078155218765635
- By:
- Publication type:
- Article
Surface contamination of counting tools after mock dispensing of cyclophosphamide in a simulated outpatient pharmacy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 85, doi. 10.1177/1078155218764587
- By:
- Publication type:
- Article
A response to the letter to the editor on Shaikh et al. Aplastic anemia secondary to propylthiouracil: A rare and life-threatening adverse effect.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 253, doi. 10.1177/1078155218765633
- By:
- Publication type:
- Article
Updates in pancreatic cancer: Modest gains and hopeful targets.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 101, doi. 10.1177/1078155218763035
- By:
- Publication type:
- Article
A response to the letter to the editor on Biomonitoring great, but do it the right way! Re: Poupeau et al. Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 252, doi. 10.1177/1078155218761801
- By:
- Publication type:
- Article
Navigating manuscript assessment: The new practitioner's guide to primary literature peer review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 94, doi. 10.1177/1078155218761222
- By:
- Publication type:
- Article
Biomonitoring great, but do it the right way!
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 246, doi. 10.1177/1078155218761800
- By:
- Publication type:
- Article
Current status of drug vial optimization use to prevent waste associated with injectable anticancer agents.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 244, doi. 10.1177/1078155218758501
- By:
- Publication type:
- Article
How can the use of closed system transfer devices to facilitate sharing of drug vials be optimised to achieve maximum cost savings?
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 205, doi. 10.1177/1078155217753890
- By:
- Publication type:
- Article
Approach to initiating QT-prolonging oncology drugs in the ambulatory setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 198, doi. 10.1177/1078155217748735
- By:
- Publication type:
- Article
Development of a flowchart for risk assessment and allocation of preparation of monoclonal antibodies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 187, doi. 10.1177/1078155217743095
- By:
- Publication type:
- Article
A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 179, doi. 10.1177/1078155217738324
- By:
- Publication type:
- Article
Current models of support from community pharmacies for patients on oral anticancer medicines.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 140, doi. 10.1177/1078155217732399
- By:
- Publication type:
- Article
A novel drug interaction between busulfan and blinatumomab.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 226, doi. 10.1177/1078155217729745
- By:
- Publication type:
- Article
A single center retrospective analysis of a protocol for high-dose methotrexate and leucovorin rescue administration.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 76, doi. 10.1177/1078155217729744
- By:
- Publication type:
- Article
Cardiotoxicity with carfilzomib at doses greater than 27 mg/m<sup>2</sup>: A case series.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 229, doi. 10.1177/1078155217729564
- By:
- Publication type:
- Article
Immunotherapy-induced autoimmune hypophysitis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 217, doi. 10.1177/1078155217727142
- By:
- Publication type:
- Article
Implementation and evaluation of medicine and therapeutic information service by clinical pharmacists in oncology care setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 60, doi. 10.1177/1078155217727141
- By:
- Publication type:
- Article
Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 68, doi. 10.1177/1078155217727140
- By:
- Publication type:
- Article
Creation and evaluation of a cancer chemotherapy order review guide for use at a community hospital.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 25, doi. 10.1177/1078155217726162
- By:
- Publication type:
- Article
Survey of guidelines and current practices for safe handling of antineoplastic and other hazardous drugs used in 24 countries.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 148, doi. 10.1177/1078155217726160
- By:
- Publication type:
- Article
Nivolumab-induced aplastic anemia: A case report and literature review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 221, doi. 10.1177/1078155217726159
- By:
- Publication type:
- Article
Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 52, doi. 10.1177/1078155217726158
- By:
- Publication type:
- Article
Real-world utilization of darbepoetin alfa in cancer chemotherapy patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 16, doi. 10.1177/1078155217725571
- By:
- Publication type:
- Article
Effectiveness of adjuvant carboplatin-based chemotherapy compared to cisplatin in non-small cell lung cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 44, doi. 10.1177/1078155217724595
- By:
- Publication type:
- Article
Parenteral product error detection before and after implementation of intravenous workflow management technology.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 5, doi. 10.1177/1078155217723695
- By:
- Publication type:
- Article